QuantaLife

About:

QuantaLife is a biotechnology company that manufactures and markets products based on their proprietary nucleic acid testing method.

Website: http://www.bio-rad.com/en-us/product/digital-pcr/qx100-droplet-digital-pcr-system

Twitter/X: quantalife

Top Investors: Paladin Capital Group, Mérieux Equity Partners

Description:

QuantaLife, Inc. was formed to develop, manufacture and market a revolutionary nucleic acid testing concept for the Life Science Research, Clinical Molecular Diagnostics, Personalized Medical Care and Industrial markets. Our suite of products, which are based on our proprietary nucleic acid testing method, will enable rapid detection and quantification of nucleic acids in complex samples on a flexible, automated instrument. This technology provides an order of magnitude improvement in performance over current platforms at a fraction of the cost. QuantaLife is a small biotechnology startup involved in the early development phases of the technology.

Total Funding Amount:

$30.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pleasanton, California, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)quantalife.com

Founders:

Ben Hindson, Kevin Ness, Michael Moniz

Number of Employees:

11-50

Last Funding Date:

2011-07-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai